Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 206 IDR -4.63% Market Closed
Market Cap: 2.3T IDR
Have any thoughts about
Pyridam Farma Tbk PT?
Write Note

Pyridam Farma Tbk PT
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pyridam Farma Tbk PT
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
Other Long-Term Assets
Rp21.1B
CAGR 3-Years
-43%
CAGR 5-Years
31%
CAGR 10-Years
22%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Other Long-Term Assets
Rp454.4B
CAGR 3-Years
-9%
CAGR 5-Years
-2%
CAGR 10-Years
8%
Kalbe Farma Tbk PT
IDX:KLBF
Other Long-Term Assets
Rp262.4B
CAGR 3-Years
24%
CAGR 5-Years
-14%
CAGR 10-Years
-5%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Other Long-Term Assets
Rp75.6B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
11%
Soho Global Health Tbk PT
IDX:SOHO
Other Long-Term Assets
Rp129.4B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Other Long-Term Assets
Rp225B
CAGR 3-Years
16%
CAGR 5-Years
-10%
CAGR 10-Years
2%
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
2.3T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
114.2 IDR
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Pyridam Farma Tbk PT's Other Long-Term Assets?
Other Long-Term Assets
21.1B IDR

Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Other Long-Term Assets amounts to 21.1B IDR.

What is Pyridam Farma Tbk PT's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
22%

Over the last year, the Other Long-Term Assets growth was -4%. The average annual Other Long-Term Assets growth rates for Pyridam Farma Tbk PT have been -43% over the past three years , 31% over the past five years , and 22% over the past ten years .

Back to Top